Erdheim‐Chester disease (ECD) is a rare non‐Langerhans histiocytosis. ECD is detected more frequently due to increased awareness of healthcare providers and improved diagnostic tools. This report describes a 51‐year‐old woman with a history of weakness, bone pain, xanthelasma palpebrarum, and diabetes insipidus. ECD is a multisystemic condition with a poor prognosis. This disease should be considered in patients with diabetes insipidus, bone pain, and multiorgan involvements.
Erdheim-Chester disease (ECD) is a rare non-Langerhans disease. This report describes a 51-year-old woman with a history of weakness, bone pain, xanthelasma palpebrarum, diabetes insipidus, and hypothyroidism. ECD is a multisystemic condition with a poor prognosis. This disease should be considered in patients with diabetes insipidus and multiorgan involvements.
Key clinical messageECD is a rare and aggressive type of non-Langerhans histiocytosis with an unknown etiology. This disease should be considered in patients with longstanding diabetes insipidus and multiorgan involvements.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.